GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
12.2644 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, MIF, PPARA |
12.157 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.3584 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
11.0969 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, MIF |
10.9947 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, FUT7, GBA2, MIF, PIM1, PPARA, TYR, XDH |
10.9947 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
10.8326 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, MIF |
10.7387 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.6035 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, NR3C1, RORC, SLC6A4, SRC, TYR |
10.059 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, AKR1C3, ALOX15, ALPL, AR, AXL, BCL2, CA2, CA9, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, MMP2, MMP9, NR3C1, POLB, PPARA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
9.78256 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP2, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
9.6904 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, AR, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, NR3C1, POLB, PPARA, RORC, SLC6A4, SRC, TYR |
9.39843 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
9.10084 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, MIF, PPARA |
9.10084 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, MIF |
8.91897 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, ALOX15, ALPL, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, NR3C1, POLB, PPARA, RORC, SLC6A4, SRC, TYR |
8.7278 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, ESR1, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KCNH2, KDR, MET, MIF, POLA1, POLB, PPARA, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
8.71342 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
8.4299 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, AKR1C3, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, NR3C1, PPARA, SLC6A4, SRC |
8.02627 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, AR, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PGR, PIM1, SLC6A4, SRC, TERT, XDH |
7.87499 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, FABP4, FUT7, GBA2, MET, MIF, PPARA |
7.8214 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HSD11B2, NR3C1, RORC, SLC6A4, SRC, TYR |
7.38105 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
7.35671 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GBA2, MIF, PPARA |
7.35106 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PGR, PIM1, PPARA, RORC, SRC |
7.15935 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, HCAR2, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.11709 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, HCAR2, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.08582 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
7.05845 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
7.02527 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.97772 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, MMP2, NR3C1, PPARA, SLC6A4, SRC |
6.94005 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
6.91881 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HCAR2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
6.87127 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
6.83701 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALOX15, ALPL, AR, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, NR3C1, RORC, SLC6A4, SRC, TERT |
6.67665 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
6.40557 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, ALPL, AR, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, KDR, MET, MIF, MMP2, MMP9, PGR, PIM1, POLB, PPARA, RORC, SLC6A4, SRC, TERT, TNKS2, TYR |
6.32277 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AKR1C3, AR, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, TERT |
6.12438 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
6.09316 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALOX15, ALPL, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MIF, MMP2, MMP9, NR3C1, POLA1, POLB, PTPN1, RORC, SLC6A4, SRC, TERT |
5.93557 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, ALOX15, ALPL, AR, AURKB, AXL, BCL2, CA2, CA6, CA9, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, MIF, MMP12, MMP2, MMP9, NR3C1, POLA1, POLB, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
5.93311 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, ALOX15, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC, TERT |
5.7658 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.7414 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
5.7017 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, POLB, PPARA, SRC, TYR |
5.59614 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GBA2, MIF, PIM1, PPARA, TYR |
5.55593 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
5.44957 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, ALOX15, ALPL, AR, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, NR3C1, RORC, SLC6A4, SRC |
5.42588 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.36949 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.29194 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
5.22409 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, RORC |
5.20613 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
5.1946 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
5.16843 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, FABP3, HSD11B2, KCNH2, KDR, NR3C1, POLB, SLC6A2, SLC6A4, SRC |
4.97521 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GBA2, MIF, PIM1, PPARA, TYR |
4.97521 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CES1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.90946 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AR, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A2, SLC6A4, SRC, TNKS2, TYR |
4.87689 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GBA2, MIF, PIM1, PPARA, TYR |
4.87424 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.86894 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CDK6, HCAR2, KDR, MIF, SRC, TNKS, TNKS2 |
4.81279 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
4.64233 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
4.53943 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.41718 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, AR, CYP1A1, CYP1B1, ESR1, FLT3, NR3C1, RORC, SLC6A4, SRC |
4.38198 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, AKR1C3, ALOX15, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
4.3532 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, SRC, TERT |
4.27742 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AXL, BCL2, CSNK2A1, CYP1B1, ESRRA, F3, FABP4, FLT3, KDR, MET, MIF, MMP12, MMP2, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
4.25077 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.24706 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, AR, BCL2, CA2, FLT3, HSD11B2, NR3C1, SRC |
4.23643 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, POLB, PPARA, SLC6A4, SRC, TERT |
4.20584 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AXL, BCL2, CYP1B1, F3, FLT3, KDR, MET, MIF, PTPN1, SRC, XDH |
4.14901 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MIF |
4.1393 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, SRC, TERT |
4.11044 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, ALPL, AR, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, MMP9, PGR, PIM1, POLB, PPARA, RORC, SRC, TYR |
4.08399 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, AKR1C3, ALOX15, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.08399 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ALOX15, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
4.03665 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
3.92028 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ALOX15, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.90694 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
3.8754 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CES1, CYP1A1, CYP1B1, KDR, POLB, SLC6A4, SRC |
3.87194 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3, GBA2 |
3.8462 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, PGR, SRC |
3.83579 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, AR, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, F3, HCAR2, IGF1R, KCNH2, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
3.80861 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, GBA2, TYR |
3.76532 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, SRC, TERT |
3.72275 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HCAR2, IGF1R, KCNH2, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
3.72275 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SLC6A4, SRC, TERT |
3.71118 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SLC6A4, SRC, TERT |
3.60531 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.5687 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, SRC, TERT |
3.53489 |
[BP] GO:0071396 |
cellular response to lipid
|
AKR1C3, AR, AXL, CDK6, ESR1, FLT3, NR3C1, RORC, SLC6A4, SRC |
3.50032 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, AR, AXL, CDK6, CYP1B1, ESR1, IGF1R, MMP2, MMP9, NR3C1, RORC, SLC6A4, SRC |
3.46547 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, MIF, SRC, TNKS, TNKS2 |
3.46484 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
3.4639 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, AKR1C3, CYP1A1, FABP3, FLT3, HCAR2, PPARA, RORC, SRC |
3.43799 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.43168 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.43168 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, MIF, PIM1, POLA1, SRC, TYR |
3.4223 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, PGR, PPARA, RORC, SLC6A4, SRC |
3.42129 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MET, MIF, MMP9, PTPN1, SRC, XDH |
3.41642 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.38906 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, BCL2, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, SRC, TERT |
3.37209 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, SRC, TERT |
3.35712 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, SRC, TERT |
3.34237 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KCNH2, KDR, MET, MIF, MMP12, MMP9, NR3C1, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
3.30355 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, ALPL, BCL2, FLT3, HSD11B2, NR3C1, SRC |
3.29341 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.26906 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.26906 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.26906 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.20789 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.13716 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HCAR2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
3.12766 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
3.11949 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.11445 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, PGR, SRC |
3.1088 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, ALOX15, BCL2, CA2, CYP1A1, CYP1A2, FABP4, MMP9, TERT |
3.07031 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, AR, BCL2, CDK6, CYP19A1, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTPN1, SRC, TERT, XDH |
3.04792 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.04447 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, BCL2, CYP1B1, MMP9, SRC |
3.01042 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, MMP2, MMP9, PGR, SLC6A4, SRC |
3.01042 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, KCNH2, MET, POLA1, POLB, SRC, TERT |
2.99551 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, AKR1C3, AR, AURKB, BCL2, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, HCAR2, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.91328 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19 |
2.8891 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, AR, AXL, BCL2, CBR1, CDC25B, CDK6, CES1, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, KDR, MET, MIF, MMP2, MMP9, PGR, RORC, SRC, TERT |
2.88349 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, AR, AXL, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, MET, MIF, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLB, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2 |
2.86882 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.85901 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.79746 |
[BP] GO:0071383 |
None
|
AKR1C3, AR, FLT3, NR3C1, SRC |
2.77583 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AR, BCL2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
2.7482 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP2C19 |
2.74563 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, AR, BCL2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
2.73758 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, SRC |
2.73758 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.71311 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.70895 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.70895 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.70895 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.70895 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.70895 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.66949 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, KCNH2, KDR, NR3C1, SRC |
2.63772 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
2.62072 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.57755 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC, TNKS |
2.56004 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, MIF, MMP9, PTPN1, SRC, TERT |
2.54932 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.51974 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.49315 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.45049 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CYP19A1, HCAR2, KCNH2, MIF, MMP12, SLC6A4, SRC, TERT |
2.43787 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.41303 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.41303 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.41303 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, PPARA, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
2.38978 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.34098 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, AR, FLT3, KDR, MIF, PTPN1, SRC, XDH |
2.34098 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTPN1, SRC |
2.33704 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, AR, BCL2, CDC25B, ESRRB, FLT3, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.33333 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, AR, AXL, BCL2, CA2, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, HCAR2, KCNH2, KDR, MET, MIF, MMP12, MMP9, PIM1, SLC6A4, SRC, TERT, TNKS2, XDH |
2.32145 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, AKR1C3, BCL2, HSD11B2 |
2.32145 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.30463 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.30463 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.30463 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.30463 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, FABP3, HSD17B2, KDR, MMP2, SLC6A4, SRC |
2.29262 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, HSD11B2, MMP2, POLB, PPARA, SLC6A4, SRC, TERT, TYR |
2.28968 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, ALOX15, CES1, CYP19A1, TYR |
2.28066 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA |
2.22906 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.22795 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.2002 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AKR1C3, ALPL, AXL, BCL2, CYP1A1, HSD11B2, SLC6A4, SRC, TYR |
2.19401 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
2.1828 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, ALOX15, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
2.16537 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CDK6, CYP19A1, ESR1, F3, FABP4, IGF1R, MET, MIF, MMP12, MMP2, PPARA, PTPN1, SRC, TERT, XDH |
2.16281 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.15919 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.15919 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1C3, ALOX15, AR, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
2.15886 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, MIF, PTPN1, SRC |
2.15082 |
[BP] GO:0044242 |
None
|
AKR1B10, AKR1C3, CYP1B1, FABP3, FABP4, GBA2 |
2.15082 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, BCL2, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.13875 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
2.13875 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.13567 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, MMP9, TERT |
2.13567 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, NR3C1, SRC |
2.0952 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, POLB, PTPN1, SRC, TNKS, XDH |
2.08536 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, PPARA |
2.08536 |
[BP] GO:0090344 |
None
|
CDK6, MIF, TERT |
2.07655 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.07655 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.07655 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.07655 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SRC, TERT, TNKS, TNKS2 |
2.07653 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.07653 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.07653 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.07653 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, AR, ESR1, FLT3, IGF1R, MMP2, NR3C1, SLC6A4, SRC |
2.06163 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, AR, BCL2, CDC25B, ESRRB, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
2.05974 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, BCL2, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.05974 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.05855 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SRC, TERT, TNKS, TNKS2 |
2.05425 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.05425 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.04089 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, AKR1C3, AR, AURKB, BCL2, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, IGF1R, MET, MIF, MMP12, MMP9, NR3C1, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.03869 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.0279 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, AR, BCL2, CDC25B, FLT3, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.02262 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, AR, AURKB, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KCNH2, KDR, MIF, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, PTPN1, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
3.22747 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, NR3C2, PTPN1 |
2.7277 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, GBA2, HSD11B1, HSD11B2, HSD17B2, NR3C2 |
2.11206 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
1.77645 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALOX5, ALPL, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP2, NR3C2, PGR, PIM1, PTPN1, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR |
1.70364 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
21.9139 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.6324 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PTPN1, SRC, TERT, TNKS, TNKS2, TYR, XDH |
12.8662 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, PTPN1, RORC, TNKS |
11.5774 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
11.5774 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
10.7626 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.6035 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
10.3035 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, NR3C1, NR3C2, PGR, RORC |
10.2209 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TNKS, TNKS2, TYR, XDH |
10.0506 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TNKS, TNKS2, TYR, XDH |
9.72806 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
8.20457 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
7.87499 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
7.87499 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, XDH |
7.53508 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, TYR |
7.05845 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
7.02381 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
6.99397 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.48227 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, NR3C1, NR3C2, PGR, PPARA, RORC |
6.23063 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, TYR |
5.36949 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19 |
5.10643 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.08229 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.05496 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, SRC |
4.87162 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, HSD11B2, HSD17B1, POLA1, SRC, XDH |
4.73346 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.73221 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, SRC |
4.64233 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC |
4.64233 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.58647 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19 |
4.25077 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, CDK6, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC |
4.22433 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC |
3.86217 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
3.75679 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, AR, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, ESR1, ESR2, ESRRB, F3, KCNH2, MET, MIF, NR3C1, PGR, POLA1, POLB, PPARA, PTPN1, SLC6A4, SRC, TNKS2 |
3.72107 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC |
3.27514 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.11445 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC |
2.8844 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.70895 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.70895 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.70895 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.70895 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.67619 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC |
2.65834 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, BCL2, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MET, MIF, MMP9, PGR, SLC6A4, TERT, TYR, XDH |
2.57755 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, NR3C1 |
2.54213 |
[MF] GO:0008392 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.34098 |
[MF] GO:0008391 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.34098 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.30463 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.30463 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.30463 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SLC6A4, SRC |
2.28737 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, POLA1, POLB, SRC, TERT |
2.2584 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.1828 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.16824 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.13567 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.07653 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.07653 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.07653 |